GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Wandong Medical Technology Co Ltd (SHSE:600055) » Definitions » 5-Year Sharpe Ratio

Beijing Wandong Medical Technology Co (SHSE:600055) 5-Year Sharpe Ratio : 0.17 (As of Jul. 16, 2025)


View and export this data going back to 1997. Start your Free Trial

What is Beijing Wandong Medical Technology Co 5-Year Sharpe Ratio?

The 5-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past five years. As of today (2025-07-16), Beijing Wandong Medical Technology Co's 5-Year Sharpe Ratio is 0.17.


Competitive Comparison of Beijing Wandong Medical Technology Co's 5-Year Sharpe Ratio

For the Medical Devices subindustry, Beijing Wandong Medical Technology Co's 5-Year Sharpe Ratio, along with its competitors' market caps and 5-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Wandong Medical Technology Co's 5-Year Sharpe Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Beijing Wandong Medical Technology Co's 5-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Beijing Wandong Medical Technology Co's 5-Year Sharpe Ratio falls into.


;
;

Beijing Wandong Medical Technology Co 5-Year Sharpe Ratio Calculation

The 5-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset in the last five years. A stock / portfolio's 5-Year Sharpe Ratio can be calculated by dividing the difference between the five-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the investment returns over the past five years.


Beijing Wandong Medical Technology Co  (SHSE:600055) 5-Year Sharpe Ratio Explanation

The 5-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past five years. It is calculated as the annualized result of the average five-year monthly excess returns divided by its standard deviation in the five-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


Beijing Wandong Medical Technology Co 5-Year Sharpe Ratio Related Terms

Thank you for viewing the detailed overview of Beijing Wandong Medical Technology Co's 5-Year Sharpe Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Wandong Medical Technology Co Business Description

Traded in Other Exchanges
N/A
Address
Jiuxianqiao East Road, 9th Floor, Building 3, Chaoyang District, Beijing, CHN, 100015
Beijing Wandong Medical Technology Co Ltd is engaged in the development, manufacture, and distribution of medical equipment. Its products consist of radiological imaging equipment, including angiographic and cardiac systems, digital direct radiography (DR) imaging equipment, high frequency diagnostic systems, high frequency radiographic systems, conventional x-ray diagnostic equipment and high frequency mobile units, magnetic resonance imaging (MRI) equipment, as well as digital medical image management systems, among others. The company is also engaged in providing maintenance services.
Executives
Zhang Dan Shi Supervisors
Yang Li senior management
Gao En Yi senior management
Liu Hai Chen senior management
Jiang Da Director
Wu Guang Ming Director
Wang Wan Liang Director
Xu Jia Ju Director

Beijing Wandong Medical Technology Co Headlines

No Headlines